PARLIAMENTARY WRITTEN QUESTION
Drugs and Medical Treatments: Brexit (19 October 2020)

To ask the Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, pursuant to his oral contribution of 19 October 2020, Official Report, whether cross-border supply chains of medicines for the care and treatment of patients will continue without disruption after the transition period.

Asked by:
Christine Jardine (Liberal Democrat)

The Government, pharmaceutical industry and NHS work closely together to help ensure patients have access to the medicines and treatments they need.

The Department for Health and Social Care is working with trade bodies, product suppliers, and the health and care system to ensure continued supply of medicines and medical products at the end of the transition period. The Government has also written to medical suppliers about what steps they need to take.

Answered by:
Penny Mordaunt (Conservative)
22 October 2020